Hyper-concentrated investor—saying no ~99% of the time—backing brands at the tipping point of consumer behavior shifts and delivering brand/marketing expertise plus brand experts and creative operators. With a disciplined investment approach, the team drives value for both founders and investors.
Ranked by shared stages, industries, geography, cheque size and investor type. 400 related investors in the directory.
Early-phase partner for founders building iconic, industry-transforming companies, demonstrated by two new funds totaling $347M. With a disciplined investment approach, the team drives value for both founders and investors.
Invests at the pre-venture stage, applies a proprietary Villain Test to avoid future-harmful giants, features rapid small grants to de-risk climate ideas, and backs culture-shaping consumer brands. With a disciplined investment approach, the team drives value for both founders and investors.
Women-led VC systematically backs clinically rigorous, behaviorally grounded wellbeing nascent-stage companies tackling stigmatized areas—alcohol use disorder, menopause, mental health—using stigma as an investing edge and insisting on consumer-grade UX. With a disciplined investment approach, the team drives value for both founders and investors.
Seed and formative-stage lead/co-lead investor backing veteran teams in education, safety & care, and environment/climate, delivering Goldman-level analytical rigor and explicit, quantified impact theses. With a disciplined investment approach, the team drives value for both founders and investors.
Offers strictly non-dilutive term loans without warrants, tailored to B2B SaaS businesses in the $1M to $10M ARR range. The firm prioritizes capital-efficient, niche vertical SaaS companies and openly shares its revenue-financing frameworks and underwriting methodologies.
Deliberate 60/40 tech/healthcare split dedicated to de novo company formation, with a transparent debate-driven partner scoring system (1–4) and proven multi-generation continuity. With a clear focus on healthcare innovation, the firm brings both capital and domain expertise.
